Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.28B
-
Number of holders
-
1907
-
Total 13F shares, excl. options
-
1.08B
-
Shares change
-
-2.76M
-
Total reported value, excl. options
-
$84B
-
Value change
-
-$238M
-
Put/Call ratio
-
0.61
-
Number of buys
-
778
-
Number of sells
-
-1028
-
Price
-
$77.72
Significant Holders of Medtronic plc - Common Stock (MDT) as of Q4 2022
2,133 filings reported holding MDT - Medtronic plc - Common Stock as of Q4 2022.
Medtronic plc - Common Stock (MDT) has 1,907 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.08B shares
of 1.28B outstanding shares and own 84.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (125M shares), BlackRock Inc. (122M shares), STATE STREET CORP (60M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (35.4M shares), WELLINGTON MANAGEMENT GROUP LLP (29.9M shares), Capital Research Global Investors (28.8M shares), GEODE CAPITAL MANAGEMENT, LLC (27.2M shares), BANK OF AMERICA CORP /DE/ (23.6M shares), JPMORGAN CHASE & CO (20M shares), and Bank of New York Mellon Corp (19.6M shares).
This table shows the top 1907 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.